Paresh P.
About Paresh P.
Paresh P. is an Associate Marketing Director at Alkermes, focusing on the LYBALVI Schizophrenia and Bipolar 1 Disorder launch, and also works as a Pharmaceutical Product Management Consultant at Paresh Patel Enterprises.
Company
Paresh P. is currently working at Alkermes as Associate, Marketing Director in the LYBALVI Schizophrenia and Bipolar 1 Disorder Launch Marketing division, based in Waltham, Massachusetts. He also operates Paresh Patel Enterprises as a Pharmaceutical Product Management Consultant in Mechanicsburg, Pennsylvania.
Title
As an Associate Marketing Director for LYBALVI Schizophrenia and Bipolar 1 Disorder Launch Marketing at Alkermes, Paresh P. handles multiple crucial functions in launching and promoting LYBALVI. His involvement includes defining healthcare provider (HCP) segmentation and leading promotion strategies.
Education and Expertise
Paresh P. holds a Master of Business Administration (MBA) from Carnegie Mellon University - Tepper School of Business, where he studied Strategy, Marketing, and Finance. He also has a Bachelor of Science in Chemical Engineering/Biomedical Engineering from Carnegie Mellon University. His education has laid a strong foundation for his marketing roles in the pharmaceutical industry.
Career Background
Paresh P. has extensive marketing experience, including roles at various pharmaceutical companies. He has worked at Harvest, Inc. as Director of New Products and Innovation, at Sunovion Pharmaceuticals Inc. as Director of Neurology Marketing - Lifecycle, and at Novo Nordisk A/S as Marketing Manager for Pipeline Products. He also has experience as a Marketing Manager at LifeCell Corporation and held multiple roles at Merck & Co. and W&H.
Achievements in Launching LYBALVI
Paresh P. has significantly contributed to the successful launch of LYBALVI. He defined the HCP early adopter segmentation, leading to a 4-fold greater conversion ratio upon calls compared to non-early adopters. He also served as the Market Research & Analytics point for analyzing drivers and barriers to prescribing LYBALVI, managed sample forecasting, and led various promotional initiatives including agency management and message development.